Related references
Note: Only part of the references are listed.Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII
Sanjay Rathod et al.
HAEMATOLOGICA (2019)
Severe pegaspargase hypersensitivity reaction rates (grade 3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials
Michael J. Burke et al.
LEUKEMIA & LYMPHOMA (2018)
Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia
Mehrdad Hefazi et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress
Hiroaki Goto
PEDIATRICS INTERNATIONAL (2015)
Clinical Application of Asparaginase Activity Levels Following Treatment With Pegaspargase
Archie Bleyer et al.
PEDIATRIC BLOOD & CANCER (2015)
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy
Wing H. Tong et al.
HAEMATOLOGICA (2013)
Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: Premedication and desensitization may not be sufficient
Umit M. Sahiner et al.
PEDIATRICS INTERNATIONAL (2013)
Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization
Mariana Castells et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia
C. Liu et al.
LEUKEMIA (2012)
L-Asparaginase Treatment in Acute Lymphoblastic Leukemia
Rob Pieters et al.
CANCER (2011)
Biology and Treatment of Acute Lymphoblastic Leukemia
Rob Pieters et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
A Desensitization Protocol in Children With L-Asparaginase Hypersensitivity
Sinan Akbayram et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Rapid Desensitization for Hypersensitivity Reactions to Medications
Mariana Castells
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2009)
Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia
Ozge Uysal Soyer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
Anja Moericke et al.
BLOOD (2008)
Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
Mariana C. Castells et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
Albert Moghrabi et al.
BLOOD (2007)
FDA drug approval summary: Pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
Patricia Anne Dinndorf et al.
ONCOLOGIST (2007)
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse:: A children's oncology group study (CCG-1941)
Mohammad Jarrar et al.
PEDIATRIC BLOOD & CANCER (2006)
Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments
AM Feldweg et al.
GYNECOLOGIC ONCOLOGY (2005)
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia - Children's Cancer Group Study CCG-1961
EH Panosyan et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
CH Pui et al.
BLOOD (2004)
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:: a Children's Cancer Group study
VI Avramis et al.
BLOOD (2002)
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment
HJ Müller et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
LB Silverman et al.
BLOOD (2001)
Share Paper
